Evaluation of an anticoagulation management method based on mobile health technology and artificial intelligence / 中华健康管理学杂志
Chinese Journal of Health Management
; (6): 368-372, 2021.
Artículo
en Chino
| WPRIM (Pacífico Occidental)
| ID: wpr-910849
Biblioteca responsable:
WPRO
ABSTRACT
Objective:
To evaluate an anticoagulation management method based on mobile health technology and artificial intelligence.Methods:
The study was a single-center, prospective, randomized, controlled, non-inferiority clinical trial. From November 2017 to September 2018, 67 patients who received warfarin therapy after mechanical valve replacement were consecutively enrolled and randomized into two groups 34 were randomized to intervention group and 33 to control group. The intervention group was managed via Anticlot Assistant and the control group was handled as routine care. Evaluations were performed at least 3 months after enrollment and ended on 30 September 2019. Non-inferiority was evaluated using one-sided tests with a non-inferiority margin set 11.0% for time in therapeutic range (TTR) and 10.0% for the percentage of international normalized ratio (INR) in the therapeutic range.Results:
The mean TTR was (58.2±23.4)% in the intervention group and (54.8±23.6)% in the control (the difference 3.4%; low limit of one-side 95% confidence interval for the difference -6.4%; and P value for non-inferiority was 0.009). The percentage of INR in the therapeutic range was (55.4±21.9)% in the intervention group and (52.8±22.5)% in the control (the difference 2.6%, low limit of one-side 95% confidence interval for the difference -6.6%; and P value for non-inferiority was 0.012).Conclusion:
The outcomes of patients managed via the anticoagulation management method base on mobile health technology and artificial intelligence are not inferior to those handled as routine care.
Texto completo:
Disponible
Contexto en salud:
ODS3 - Salud y Bienestar
Problema de salud:
Meta 3.8: Alcanzar cobertura universal de salud
Base de datos:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Ensayo clínico controlado
Idioma:
Chino
Revista:
Chinese Journal of Health Management
Año:
2021
Tipo del documento:
Artículo